Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 2042980, 8 pages
https://doi.org/10.1155/2017/2042980
Research Article

All-Cause Mortality Risk in Australian Women with Impaired Fasting Glucose and Diabetes

1Deakin University, Geelong, VIC 3220, Australia
2Department of Medicine-Western Health, Melbourne Medical School, The University of Melbourne, St Albans, VIC 3010, Australia
3Barwon Health, Geelong, VIC 3220, Australia

Correspondence should be addressed to Lelia L. F. de Abreu; ua.gro.htlaehnowrab@uerbaedl

Received 29 March 2017; Revised 15 May 2017; Accepted 23 May 2017; Published 18 June 2017

Academic Editor: Mark A. Yorek

Copyright © 2017 Lelia L. F. Abreu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Yeboah, A. G. Bertoni, D. M. Herrington, W. S. Post, and G. L. Burke, “Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis),” Journal of the American College of Cardiology, vol. 58, no. 2, pp. 140–146, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Laukkanen, T. H. Makikallio, K. Ronkainen, J. Karppi, and S. Kurl, “Impaired fasting plasma glucose and type 2 diabetes are related to the risk of out-of-hospital sudden cardiac death and all-cause mortality,” Diabetes Care, vol. 36, no. 5, pp. 1166–1171, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. K. T. Chen, C. J. Chen, E. W. Gregg, G. Imperatore, and K. M. Narayan, “Impaired fasting glucose and risk of diabetes in Taiwan: follow-up over 3 years,” Diabetes Research and Clinical Practice, vol. 60, no. 3, pp. 177–182, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. M. Gabir, R. L. Hanson, D. Dabelea et al., “The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes,” Diabetes Care, vol. 23, no. 8, pp. 1108–1112, 2000. View at Publisher · View at Google Scholar
  5. O. R. Pour and S. Dagogo-Jack, “Prediabetes as a therapeutic target,” Clinical Chemistry, vol. 57, no. 2, pp. 215–220, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. N. G. Forouhi, J. Luan, S. Hennings, and N. J. Wareham, “Incidence of type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000,” Diabetic Medicine, vol. 24, no. 2, pp. 200–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. D. J. Magliano, E. L. Barr, P. Z. Zimmet et al., “Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian diabetes,” Obesity and Lifestyle Study. Diabetes Care, vol. 31, no. 2, pp. 267–272, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Zimmet, “Diabesity in Australia: an affair of the heart,” Heart, Lung & Circulation, vol. 12, Supplement 2, pp. S95–S98, 2003. View at Google Scholar
  9. S. Genuth, K. G. Alberti, P. Bennett et al., “Follow-up report on the diagnosis of diabetes mellitus,” Diabetes Care, vol. 26, no. 11, pp. 3160–3167, 2003. View at Google Scholar
  10. L. de Abreu, K. L. Holloway, M. A. Kotowicz, and J. A. Pasco, “Dysglycaemia and other predictors for progression or regression from impaired fasting glucose to diabetes or normoglycaemia,” Journal of Diabetes Research, vol. 2015, Article ID 373762, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Ritz, I. Rychlik, F. Locatelli, and S. Halimi, “End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions,” American Journal of Kidney Diseases, vol. 34, no. 5, pp. 795–808, 1999. View at Publisher · View at Google Scholar
  12. R. Klein, B. E. Klein, S. E. Moss, and K. J. Cruickshanks, “The Wisconsin epidemiologic study of diabetic retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes,” Ophthalmology, vol. 105, no. 10, pp. 1801–1815, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Harris, R. Eastman, and C. Cowie, “Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population,” Diabetes Care, vol. 16, no. 11, pp. 1446–1452, 1993. View at Publisher · View at Google Scholar
  14. C. Trautner, B. Haastert, G. Giani, and M. Berger, “Incidence of lower limb amputations and diabetes,” Diabetes Care, vol. 19, no. 9, pp. 1006–1009, 1996. View at Publisher · View at Google Scholar
  15. G. Roglic and N. Unwin, “Mortality attributable to diabetes: estimates for the year 2010,” Diabetes Research and Clinical Practice, vol. 87, no. 1, pp. 15–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Gu, C. C. Cowie, and M. I. Harris, “Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993,” Diabetes Care, vol. 21, no. 7, pp. 1138–1145, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. C. D. Mathers and D. Loncar, “Projections of global mortality and burden of disease from 2002 to 2030,” PLoS Medicine, vol. 3, no. 11, article e442, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. “Diabetes Australia. Diabetes Australia welcomes coalition health policy focus on a better response to the rising diabetes epidemic,” 2013, September 2014, http://www.diabetesvic.org.au/component/content/article/810. View at Publisher · View at Google Scholar
  19. J. S. Pankow, D. K. Kwan, B. B. Duncan et al., “Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the atherosclerosis risk in communities study,” Diabetes Care, vol. 30, no. 2, pp. 325–331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Wang, S. Ruotsalainen, L. Moilanen, P. Lepisto, M. Laakso, and J. Kuusisto, “The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns,” European Heart Journal, vol. 28, no. 7, pp. 857–864, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Deedwania, K. Patel, G. C. Fonarow et al., “Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study,” International Journal of Cardiology, vol. 168, no. 4, pp. 3616–3622, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. J. A. Pasco, G. C. Nicholson, and M. A. Kotowicz, “Cohort profile: Geelong Osteoporosis Study,” International Journal of Epidemiology, vol. 41, pp. 1565–1575, 2012. View at Google Scholar
  23. World Health Organization, Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity, World Health Organization, Geneva, 2000.
  24. “Physical fitness and athletic performance: joint position of the Canadian Dietetic Association and the American Dietetic Association,” Journal of the Canadian Dietetic Association, vol. 54, no. 2, pp. 81-82, 1993.
  25. A. D. B. Kunst and J. Ziegenhorn, UV-Methods with Hexokinase and Glucose-6-phosphate Dehydrogenase, Chemie, Weinheim, Germany, 3rd edition edition, 1983.
  26. World Health Organization, Prevention of cardiovascular disease: pocket guidelines for assessment and management of cardiovascular risk, World Health Organization, Geneva, 2007.
  27. K. G. Alberti, P. Zimmet, and J. Shaw, “The metabolic syndrome—a new worldwide definition,” Lancet, vol. 366, no. 9491, pp. 1059–1062, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Saracci, “Survival-related biases survive well,” International Journal of Epidemiology, vol. 36, no. 1, pp. 244–246, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Ryden, P. J. Grant, S. D. Anker et al., “ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD),” European Heart Journal, vol. 34, no. 39, pp. 3035–3087, 2013. View at Google Scholar
  30. A. Stokes and S. H. Preston, “Deaths attributable to diabetes in the United States: comparison of data sources and estimation approaches,” PloS One, vol. 12, no. 1, article e0170219, 2017. View at Publisher · View at Google Scholar
  31. Y. Huang, X. Cai, P. Chen et al., “Associations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis,” Annals of Medicine, vol. 46, no. 8, pp. 684–692, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. DECODE Study Group on behalf of the European Diabetes Epidemiology Group, “Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies,” Diabetologia, vol. 42, pp. 647–654, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. R. de Marco, F. Locatelli, G. Zoppini, G. Verlato, E. Bonora, and M. Muggeo, “Cause-specific mortality in type 2 diabetes,” The Verona Diabetes Study. Diabetes Care., vol. 22, no. 5, pp. 756–761, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Al-Rubeaan, A. M. Youssef, H. M. Ibrahim et al., “All-cause mortality and its risk factors among type 1 and type 2 diabetes mellitus in a country facing diabetes epidemic,” Diabetes Research and Clinical Practice, vol. 118, pp. 130–139, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. S. H. Saydah, M. S. Eberhardt, C. M. Loria, and F. L. Brancati, “Age and the burden of death attributable to diabetes in the United States,” American Journal of Epidemiology, vol. 156, no. 8, pp. 714–719, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. J. A. Pasco, K. L. Holloway, A. G. Dobbins, M. A. Kotowicz, L. J. Williams, and S. L. Brennan, “Body mass index and measures of body fat for defining obesity and underweight: a cross-sectional, population-based study,” BMC Obesity, vol. 1, p. 9, 2014. View at Google Scholar